tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Champions Oncology Inc

CSBR
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
5.096USD
+0.086+1.72%
์ข…๊ฐ€ย 09-09 16:00๏ผˆET๏ผ‰
69.43M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM
์žฅ์™ธ ๊ฑฐ๋ž˜ย ย (ET)0.000USD0.000

CSBR ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Champions Oncology Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ

์‹œ๊ฐ€์ด์•ก
69.43M
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
-28.90
์ฃผ๋‹น์ˆœ์ด์ต
-0.17
์ˆ˜์ต
59.42M
์ˆœ์ด์ต
4.70M
ROE
-48.05%
ROA
-7.93%

Champions Oncology Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜

์ตœ์‹  ์ถœ์‹œ
Sep 10, 2026
EPS / ์˜ˆ์ƒ
--/-0.01
์ˆ˜์ต / ์˜ˆ์ƒ
--/15.04M

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q4
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
์žฌ๋ฌด ์ง€ํ‘œ
EPS
64.01%-0.05
-106.12%-0.02
-63.72%0.02
-132.74%-0.03
-1558.66%-0.13
276.29%0.33
134.90%0.05
150.84%0.10
95.75%-0.01
-3.46%-0.19
-12903.39%-0.15
---0.19
---0.19
---0.18
--0.00
---0.02
----
----
----
----
์ˆ˜์ต
11.98%13.84M
-2.82%16.56M
11.46%15.04M
-0.47%13.99M
-11.76%12.36M
41.77%17.04M
16.56%13.49M
11.94%14.06M
7.12%14.00M
-5.90%12.02M
-18.96%11.57M
-8.61%12.56M
1.51%13.07M
-3.18%12.77M
21.17%14.28M
22.15%13.74M
21.90%12.88M
22.02%13.19M
16.50%11.79M
17.87%11.25M
์ˆœ์ด์ต
63.65%-667.00K
-106.21%-279.00K
-63.19%268.00K
-133.21%-436.00K
-1583.49%-1.83M
277.67%4.50M
135.15%728.00K
151.17%1.31M
95.74%-109.00K
-3.73%-2.53M
-12843.75%-2.07M
-704.39%-2.57M
-644.48%-2.56M
-409.91%-2.44M
-105.78%-16.00K
-85.47%-319.00K
24.23%-344.00K
-17.94%787.00K
27600.00%277.00K
-329.33%-172.00K
์ˆœ์ด์ต๋ฅ 
67.54%-4.82%
-106.39%-1.68%
-70.79%1.58%
-135.66%-3.33%
-1807.91%-14.85%
225.32%26.38%
130.16%5.40%
145.71%9.34%
96.03%-0.78%
-10.24%-21.05%
-15872.06%-17.90%
---20.43%
---19.59%
---19.09%
---0.11%
---2.32%
----
----
----
----
์ด ์ด์ต๋ฅ 
23.40%50.78%
-23.73%46.65%
15.06%51.70%
-13.75%42.87%
-14.67%41.15%
76.29%61.17%
4.95%44.93%
28.02%49.70%
9.94%48.22%
-12.66%34.70%
-10.58%42.82%
--38.83%
--43.86%
--39.72%
--47.88%
--48.69%
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
-53.15%0.32%
-56.18%0.37%
-59.57%0.47%
-55.39%0.60%
--0.68%
--0.84%
--1.17%
--1.34%
----
----
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
----
์ˆ˜์ต
11.98%13.84M
-2.82%16.56M
11.46%15.04M
-0.47%13.99M
-11.76%12.36M
41.77%17.04M
16.56%13.49M
11.94%14.06M
7.12%14.00M
-5.90%12.02M
-18.96%11.57M
-8.61%12.56M
1.51%13.07M
-3.18%12.77M
21.17%14.28M
22.15%13.74M
21.90%12.88M
22.02%13.19M
16.50%11.79M
17.87%11.25M
์˜์—… ์ด์ต
69.60%-521.00K
-104.16%-187.00K
-74.73%185.00K
-138.15%-507.00K
-1145.12%-1.71M
274.58%4.50M
137.44%732.00K
152.08%1.33M
109.57%164.00K
-4.84%-2.58M
-28028.57%-1.96M
-798.59%-2.55M
-449.36%-1.71M
-396.14%-2.46M
-97.34%7.00K
-13.60%-284.00K
27.27%-312.00K
-15.48%830.00K
3657.14%263.00K
-380.77%-250.00K
์ˆœ์ด์ต
63.65%-667.00K
-106.21%-279.00K
-63.19%268.00K
-133.21%-436.00K
-1583.49%-1.83M
277.67%4.50M
135.15%728.00K
151.17%1.31M
95.74%-109.00K
-3.73%-2.53M
-12843.75%-2.07M
-704.39%-2.57M
-644.48%-2.56M
-409.91%-2.44M
-105.78%-16.00K
-85.47%-319.00K
24.23%-344.00K
-17.94%787.00K
27600.00%277.00K
-329.33%-172.00K
์œ ๋™์ž์‚ฐ
-14.08%19.22M
2.48%20.18M
51.46%21.33M
59.46%21.01M
64.01%22.37M
49.24%19.70M
0.48%14.08M
-11.69%13.18M
-29.90%13.64M
-35.17%13.20M
-31.98%14.02M
-18.77%14.92M
-1.05%19.46M
14.22%20.36M
50.40%20.61M
45.86%18.37M
55.69%19.66M
27.60%17.82M
-8.59%13.70M
2.05%12.60M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
-16.48%19.92M
4.06%20.68M
17.39%22.14M
18.44%22.70M
10.73%23.85M
-9.55%19.87M
-9.97%18.86M
-5.98%19.16M
-0.88%21.54M
5.64%21.97M
11.82%20.95M
22.64%20.38M
24.34%21.73M
34.18%20.80M
50.31%18.74M
42.34%16.62M
56.08%17.48M
35.79%15.50M
-2.27%12.46M
5.33%11.68M
์ด ์ž์‚ฐ
-16.56%26.99M
-7.12%28.45M
19.50%30.16M
22.51%30.55M
23.77%32.34M
14.34%30.63M
-10.79%25.24M
-16.63%24.93M
-23.84%26.13M
-25.90%26.79M
-22.19%28.29M
-13.04%29.91M
-3.02%34.31M
7.64%36.15M
24.13%36.36M
22.35%34.39M
28.22%35.38M
32.95%33.58M
13.73%29.30M
23.17%28.11M
๋ถ€์ฑ„ ์ด๊ณ„
-19.78%22.92M
-4.33%24.07M
5.59%25.93M
6.90%27.01M
1.92%28.57M
-12.78%25.16M
-12.91%24.56M
-9.78%25.27M
-5.53%28.04M
-0.83%28.84M
3.71%28.20M
10.22%28.00M
12.91%29.68M
19.46%29.09M
28.11%27.19M
23.51%25.41M
30.35%26.28M
39.99%24.35M
12.50%21.23M
18.85%20.57M
์ž๋ณธ ์ด๊ณ„
7.85%4.07M
-19.95%4.38M
521.29%4.23M
1165.66%3.54M
298.21%3.77M
365.74%5.47M
632.26%681.00K
-117.45%-332.00K
-141.05%-1.90M
-129.13%-2.06M
-98.99%93.00K
-78.82%1.90M
-49.03%4.64M
-23.52%7.06M
13.64%9.17M
19.17%8.98M
22.46%9.10M
17.40%9.24M
17.09%8.07M
36.73%7.54M
์ˆœ์˜์—…์ด์ต
-129.09%-2.00M
-373.27%-1.34M
-513.07%-1.74M
80.06%560.00K
478.19%6.87M
153.32%490.00K
-148.05%-283.00K
107.79%311.00K
-162.43%-1.82M
-158.42%-919.00K
-82.08%589.00K
-1946.67%-3.99M
-186.93%-692.00K
-63.05%1.57M
167.59%3.29M
-190.28%-195.00K
140.20%796.00K
3053.33%4.26M
39.70%1.23M
130.21%216.00K
์ˆœํˆฌ์ž
5.93%-238.00K
66.67%-14.00K
-157.45%-242.00K
---46.00K
-327.93%-253.00K
66.67%-42.00K
-18.99%-94.00K
100.00%0.00
114.61%111.00K
83.29%-126.00K
86.92%-79.00K
11.41%-668.00K
-50.20%-760.00K
-86.17%-754.00K
-6.71%-604.00K
16.87%-754.00K
39.33%-506.00K
66.33%-405.00K
-11.86%-566.00K
-44.89%-907.00K
์ˆœ์žฌ๋ฌดํ™œ๋™
40.63%-19.00K
---36.00K
-29.71%168.00K
62.16%-14.00K
77.93%-32.00K
--0.00
78.36%239.00K
93.73%-37.00K
-93.33%-145.00K
--0.00
55.81%134.00K
---590.00K
-568.75%-75.00K
-100.00%0.00
-28.93%86.00K
-100.00%0.00
-77.78%16.00K
221.43%68.00K
-90.22%121.00K
103.45%2.00K

์ˆ˜์ต๎˜

์‚ฌ์—…๋ณ„

์ฃผ๊ธฐ:
๋ฐ์ดํ„ฐ ์—†์Œ

์ง€์—ญ๋ณ„

์ฃผ๊ธฐ:
๋ฐ์ดํ„ฐ ์—†์Œ

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Champions Oncology Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Champions Oncology Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 59.42M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 56.94M์ž…๋‹ˆ๋‹ค.

Champions Oncology Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Champions Oncology Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 19.22M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -14.08์ž…๋‹ˆ๋‹ค.

Champions Oncology Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Champions Oncology Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Champions Oncology Inc์˜ ์ด์ž์‚ฐ์€ 26.99M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -16.56์ž…๋‹ˆ๋‹ค.

Champions Oncology Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Champions Oncology Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Champions Oncology Inc์˜ ์ด๋ถ€์ฑ„๋Š” 22.92M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -19.78์ž…๋‹ˆ๋‹ค.

Champions Oncology Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Champions Oncology Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Champions Oncology Inc์˜ ์ด์ž๋ณธ์€ 4.07M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 7.85์ž…๋‹ˆ๋‹ค.

Champions Oncology Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Champions Oncology Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Champions Oncology Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -1.03M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -121.23์ž…๋‹ˆ๋‹ค.

Champions Oncology Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Champions Oncology Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Champions Oncology Inc์˜ ์ˆœํˆฌ์ž๋Š” -540.00K์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -38.82์ž…๋‹ˆ๋‹ค.

Champions Oncology Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Champions Oncology Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Champions Oncology Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 99.00K์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -41.76์ž…๋‹ˆ๋‹ค.

Champions Oncology Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Champions Oncology Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -0.08์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -124.68์ž…๋‹ˆ๋‹ค.

Champions Oncology Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Champions Oncology Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -1.18M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -124.99์ž…๋‹ˆ๋‹ค.

Champions Oncology Inc์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Champions Oncology Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ -1.98์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -123.95์ž…๋‹ˆ๋‹ค.

Champions Oncology Inc์˜ ๋งค์ถœ์ด์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Champions Oncology Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์ด์ด์ต๋ฅ ์€ 48.00์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -4.28์ž…๋‹ˆ๋‹ค.

Champions Oncology Inc์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Champions Oncology Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 0.32์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -53.15์ž…๋‹ˆ๋‹ค.

Champions Oncology Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Champions Oncology Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -30.48์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -106.06์ž…๋‹ˆ๋‹ค.

Champions Oncology Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Champions Oncology Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -3.96์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -124.63์ž…๋‹ˆ๋‹ค.

Champions Oncology Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Champions Oncology Inc์˜ FY2026 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -1.03M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -121.23์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ